Related references
Note: Only part of the references are listed.Antibody drug conjugates, targeting cancer-expressed EGFR, exhibit potent and specific antitumor activity
Eric Chun Hei Ho et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
A Review of the Current Impact of Inhibitors of Apoptosis Proteins and Their Repression in Cancer
Pierina Cetraro et al.
CANCERS (2022)
Future Therapeutic Directions for Smac-Mimetics
Emma Morrish et al.
CELLS (2020)
Targeting triple-negative breast cancers with the Smac-mimetic birinapant
Najoua Lalaoui et al.
CELL DEATH AND DIFFERENTIATION (2020)
The Multiple Roles of the IAP Super-family in cancer
Swati Kumar et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Robert J. Kreitman et al.
LEUKEMIA (2018)
Checkpoints in TNF-Induced Cell Death: Implications in Inflammation and Cancer
Alessandro Annibaldi et al.
TRENDS IN MOLECULAR MEDICINE (2018)
Applications of chemogenomic library screening in drug discovery
Lyn H. Jones et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Essential role for Bim in mediating the apoptotic and antitumor activities of immunotoxins
A. Antignani et al.
ONCOGENE (2017)
Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer
Anne M. Noonan et al.
CANCER (2016)
A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma
Ravi K. Amaravadi et al.
MOLECULAR CANCER THERAPEUTICS (2015)
In Vitro and In Vivo Activity of the Low-Immunogenic Antimesothelin Immunotoxin RG7787 in Pancreatic Cancer
Kevin Hollevoet et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-kB Activation, and Is Active in Patient-Derived Xenograft Models
Christopher A. Benetatos et al.
MOLECULAR CANCER THERAPEUTICS (2014)
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells
Lesley A. Mathews Griner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism
Jennifer L. Allensworth et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Immunotoxins: The Role of the Toxin
Antonella Antignani et al.
TOXINS (2013)
Targeting IAP proteins for therapeutic intervention in cancer
Simone Fulda et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor
L. M. Lindqvist et al.
CELL DEATH & DISEASE (2012)
Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment
Jianfeng Lu et al.
MOLECULAR CANCER THERAPEUTICS (2011)
c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling
Jasmin N. Dynek et al.
EMBO JOURNAL (2010)
IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer
Mads Gyrd-Hansen et al.
NATURE REVIEWS CANCER (2010)
Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction
Tobias L. Haas et al.
MOLECULAR CELL (2009)
SM-164: A Novel, Bivalent Smac Mimetic That Induces Apoptosis and Tumor Regression by Concurrent Removal of the Blockade of cIAP-1/2 and XIAP
Jianfeng Lu et al.
CANCER RESEARCH (2008)
c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation
Eugene Varfolomeev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination
Mathieu J. M. Bertrand et al.
MOLECULAR CELL (2008)
Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation
D. J. Mahoney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis
Eugene Varfolomeev et al.
CELL (2007)
IAP antagonists target cIAP1 to induce TNFα- dependent apoptosis
James E. Vince et al.
CELL (2007)
Autocrine TNFα signaling renders human cancer cells susceptible to smac-mimetic-induced apoptosis
Sean L. Petersen et al.
CANCER CELL (2007)
Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer
TK Oost et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Downregulation of the antiapoptotic Mcl-1 protein and apoptosis in Ma-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin
Y Andersson et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Mechanism of XIAP-mediated inhibition of caspase-9
EN Shiozaki et al.
MOLECULAR CELL (2003)
Molecular targeting of inhibitor of apoptosis proteins based on small molecule mimics of natural binding partners
RA Kipp et al.
BIOCHEMISTRY (2002)
Recombinant immunotoxins for cancer therapy
U Brinkmann et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2001)
A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis
SM Srinivasula et al.
NATURE (2001)
Structural basis of IAP recognition by Smac/DIABLO
G Wu et al.
NATURE (2000)
Structural and biochemical basis of apoptotic activation by Smac/DIABLO
JJ Chai et al.
NATURE (2000)
Share Paper
